Skip to main content
Verity
Log in
Sign up free
MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | L36117 | Verity
Home
/
Policies
/
L36117
LCD
Retired
MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
L36117
Effective: May 15, 2025
Updated: December 5, 2025
Covered Medical Codes
This policy references 0 medical codes
View Full Code List & Coverage Details
Sign up for free to see all covered codes, disposition status, and Medicare pricing
Get Free Access
Unlock Full Policy Details
Get complete coverage criteria, all medical codes, change history, and API access
Sign Up Free
Already have an account? Log in
Original Source
View on CMS.gov
What You Get with Verity
✓
Full coverage criteria text
✓
All 0+ covered codes with dispositions
✓
Medicare fee schedule pricing
✓
Policy change alerts
✓
API access for integrations
